• COVID-19 Highlights the Need for Interoperability in Healthcare

    Apr 16 | Bio-IT World | In healthcare, the primary means of collecting patient data, the electronic health record (EHR), is one of the biggest offenders of a siloed approach to data. One need look no farther than the current pandemic to see how the lack of data-sharing infrastructure has prevented healthcare providers from getting a complete picture of their patients’ medical histories and hindered research on what treatments are working against the novel coronavirus. More

  • Bayer’s Science@Scale Platform and the Role For NVIDIA Federated Learning

    Apr 15 | Bio-IT World | NVIDIA has announced the next generation of federated learning: Clara 4.0 with global orchestration of edge clients, and an addition to privacy-preserving homomorphic encryption. David Ruau, VP, head of Global Data Assets and Decision Science at Bayer, outlined Bayer’s work with NVIDIA to incorporate Clara Federated Learning. More

  • Mutational Signatures In Cancer Improved By Supervised Machine Learning

    Apr 14 | Bio-IT World | Researchers at the Johns Hopkins Kimmel Cancer Center have a newly developed supervised machine learning algorithm that does the best job yet of connecting tissue-specific cancers to potential disease-driving factors. More

  • Pharma, Life Sciences Partnerships Driven By NVIDIA AI and Processors

    Apr 12 | Bio-IT World | At NVIDIA’s GTC event starting this week, NVIDIA CEO Jensen Huang outlined—among other things—partnerships expanding Clara Discovery, NVIDIA’s computational platform for healthcare. More

  • Collaboration Is Key to Combatting Cybercrime

    Apr 09 | Bio-IT World | Cybersecurity challenges have only escalated during the COVID-19 crisis, particularly in the fields of science and healthcare. The past year has seen a dramatic increase in the number of breaches and ransomware attacks for the enterprise networks of labs and healthcare facilities. More

  • Drugs Repurposed To Tap Immune System In Fight Against Pathogens

    Apr 06 | Bio-IT World | Researchers at the University of California (UC), San Diego have proposed that the definition of antibiotic resistance be broadened to include treatment failure among patients on appropriate antibiotic therapy, which still encompasses the “great majority of unsuccessful outcomes in infectious disease. More
View more articles
Bio IT World Lead Gen

 
Industry-spotlight

Riffyn’s pioneering cloud system, Riffyn Nexus, delivers 2X faster development cycles and 4X productivity gains to the world’s most advanced scientific R&D organizations. Its process-centric experiment design, data capture, and data analytics overcome the limitations of ELN and LIMS systems. Its adaptive data integration engine delivers results that are always ready for machine learning.
Read more here!

Industry-spotlight

Digital Therapeutics: Taking digital health to a new level
Benchling is the most widely-adopted life sciences R&D cloud. Accelerate, measure, and forecast R&D – from discovery through bioprocessing – all in one place. It’s a fully unified platform that centralizes and standardizes all R&D data, so you can spend less time fighting with legacy software, and more time reaching breakthrough discoveries.
Read more here!